The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Long-Chain ω-3 Fatty Acids for Indicated Prevention of Psychotic Disorders: A Randomized, Placebo-Controlled Trial
Open accessAbstract
CONTEXT: The use of antipsychotic medication for the prevention of psychotic disorders is controversial. Long-chain omega-3 (omega-3) polyunsaturated fatty acids (PUFAs) may be beneficial in a range of psychiatric conditions, including schizophrenia. Given that omega-3 PUFAs are generally beneficial to health and without clinically relevant adverse effects, their preventive use in psychosis merits investigation. OBJECTIVE: To determine whether omega-3 PUFAs reduce the rate of progression to first-episode psychotic disorder in adolescents and young adults aged 13 to 25 years with subthreshold psychosis. DESIGN: Randomized, double-blind, placebo-controlled trial conducted between 2004 and 2007. SETTING: Psychosis detection unit of a large public hospital in Vienna, Austria. PARTICIPANTS: Eighty-one individuals at ultra-high risk of psychotic disorder. INTERVENTIONS: A 12-week intervention period of 1.2-g/d omega-3 PUFA or placebo was followed by a 40-week monitoring period; the total study period was 12 months. MAIN OUTCOME MEASURES: The primary outcome measure was transition to psychotic disorder. Secondary outcomes included symptomatic and functional changes. The ratio of omega-6 to omega-3 fatty acids in erythrocytes was used to index pretreatment vs posttreatment fatty acid composition. RESULTS: Seventy-six of 81 participants (93.8%) completed the intervention. By study's end (12 months), 2 of 41 individuals (4.9%) in the omega-3 group and 11 of 40 (27.5%) in the placebo group had transitioned to psychotic disorder (P = .007). The difference between the groups in the cumulative risk of progression to full-threshold psychosis was 22.6% (95% confidence interval, 4.8-40.4). omega-3 Polyunsaturated fatty acids also significantly reduced positive symptoms (P = .01), negative symptoms (P = .02), and general symptoms (P = .01) and improved functioning (P = .002) compared with placebo. The incidence of adverse effects did not differ between the treatment groups. CONCLUSIONS: Long-chain omega-3 PUFAs reduce the risk of progression to psychotic disorder and may offer a safe and efficacious strategy for indicated prevention in young people with subthreshold psychotic states. Trial Registration clinicaltrials.gov Identifier: NCT00396643.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Only two studies had an overall low risk of bias 33,79 ; five had unclear risk [72][73][74][75][76] , and nine had high risk 30,31,36,37,39,41,77,78,81 .”
From Lack of evidence to favor specific preventive interventions in psychosis: a network meta‐analysis (2018) · cites this paper as [33]
In the citing paper
“Earlier studies that dominated the conclusions of some previous meta-analyses (e.g., the omega-3 trial 33 ) were likely false positives.”
From Lack of evidence to favor specific preventive interventions in psychosis: a network meta‐analysis (2018) · cites this paper as [33]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2022) · doi:10.1176/appi.books.9780890425787 · Cited by 23,476
The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
van Os, J., Linscott, R. J., Myin-Germeys, I., Delespaul, P., & Krabbendam, L. (2009) · Psychological Medicine · doi:10.1017/s0033291708003814 · Cited by 2,343
Fish Intake, Contaminants, and Human Health: Evaluating the Risks and the Benefits
Mozaffarian, D., & Rimm, E. B. (2006) · JAMA · doi:10.1001/jama.296.15.1885 · Cited by 1,966
The Family History Method Using Diagnostic Criteria
Andreasen, N. C. (1977) · Archives of General Psychiatry · doi:10.1001/archpsyc.1977.01770220111013 · Cited by 1,903
The number needed to treat: a clinically useful measure of treatment effect
Cook, R. J., & Sackett, D. L. (1995) · BMJ · doi:10.1136/bmj.310.6977.452 · Cited by 1,885
Lingjærde, O., Ahlfors, U. G., Bech, P., Dencker, S. J., & Elgen, K. (1987) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1987.tb10566.x · Cited by 1,705
Association Between Duration of Untreated Psychosis and Outcome in Cohorts of First-Episode Patients
Marshall, M., Lewis, S. W., Lockwood, A., Drake, R., Jones, P. B., & Croudace, T. J. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.9.975 · Cited by 1,595
Research works printed but not linked: 1
- First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. New York, NY: Biometrics Research, New York State Psychiatric Institute; 2002.
Cited by
Sorted by citations
Items 301–400 of 895
Guo, Y., Zhang, Y., Jia, P., Wang, W., Zhou, Q., Sun, L., Zhao, A., Zhang, X., Wang, X., Li, Y., et al. (2017) · The Journals of Gerontology Series A · doi:10.1093/gerona/glx001 · Cited by 42
Madrid-Gambín, F., Föcking, M., Sabherwal, S., Heurich, M., English, J. A., O’Gorman, A., Suvitaival, T., Ahonen, L. L., Cannon, M. D., Lewis, G., et al. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.01.018 · Cited by 46
Ketogenic diet for schizophrenia: Nutritional approach to antipsychotic treatment
Włodarczyk, A., Wiglusz, M. S., & Cubała, W. J. (2018) · Medical Hypotheses · doi:10.1016/j.mehy.2018.06.022 · Cited by 44
Paris, J., & Phillips, J. E. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6504-1 · Cited by 44
Catania, L. S., Hetrick, S. E., Newman, L. K., & Purcell, R. (2011) · Advances in Mental Health · doi:10.5172/jamh.2011.10.1.6 · Cited by 41
Food intake and blood cholesterol levels of community-based adults with mood disorders
Davison, K., & Kaplan, B. J. (2012) · BMC Psychiatry · doi:10.1186/1471-244x-12-10 · Cited by 45
Kim, S., Jhon, M., Kim, J., Smesny, S., Rice, S., Berk, M., Klier, C. M., McGorry, P. D., Schäfer, M. R., & Amminger, G. P. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151417 · Cited by 41
Self-citationEllingrod, V. L., Taylor, S. F., Brook, R. D., Evans, S. J., Zöllner, S. K., Grove, T. B., Gardner, K. M., Bly, M. J., Pop‐Busui, R., & Dalack, G. W. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.03.031 · Cited by 40
Woods, S. W., Addington, J., Bearden, C. E., Cadenhead, K. S., Cannon, T. D., Cornblatt, B. A., Mathalon, D. H., Perkins, D. O., Seidman, L. J., Tsuang, M. T., et al. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.05.019 · Cited by 40
Hashimoto, K. (2019) · Current Psychiatry Reports · doi:10.1007/s11920-019-1063-7 · Cited by 39
Ethical and Epidemiological Dimensions of Labeling Psychosis Risk
Corcoran, C. M. (2016) · The AMA Journal of Ethic · doi:10.1001/journalofethics.2016.18.6.msoc2-1606 · Cited by 40
Peroxisome proliferator-activated receptor α as a novel therapeutic target for schizophrenia
Wada, Y., Maekawa, M., Ohnishi, T., Balan, S., Matsuoka, S., Iwamoto, K., Iwayama, Y., Ohba, H., Watanabe, A., Hisano, Y., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.103130 · Cited by 38
McGorry, P. D. (2010) · Neurotoxicity Research · doi:10.1007/s12640-010-9179-x · Cited by 42
Self-citationRetractedBrain Biomarkers of Vulnerability and Progression to Psychosis
Cannon, T. D. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv173 · Cited by 41
McNamara, R. K. (2012) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2012.03.011 · Cited by 39
Clinical Staging for Youth Mental Disorders: Progress in Reforming Diagnosis and Clinical Care
McGorry, P. D., & Mei, C. (2021) · Annual Review of Developmental Psychology · doi:10.1146/annurev-devpsych-050620-030405 · Cited by 38
Self-citationA Mechanistic Approach to Preventing Schizophrenia in At-Risk Individuals
Moghaddam, B. (2013) · Neuron · doi:10.1016/j.neuron.2013.03.024 · Cited by 38
Pawełczyk, T., Grancow-Grabka, M., Trafalska, E., Szemraj, J., Żurner, N., & Pawełczyk, A. M. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05258-4 · Cited by 40
Guo, Y., Li, Y., Zhang, Y., Fang, S., Xu, X., Zhao, A., Zhang, J., Li, J. V., Ma, D., Jia, W. P., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afz132 · Cited by 38
Greasing the wheels of managing overweight and obesity with omega-3 fatty acids
Golub, N. I., Geba, D.-A., Mousa, S. A., Williams, G. C., & Block, R. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.09.016 · Cited by 40
Medema, S., Mocking, R. J. T., Koeter, M. W. J., Vaz, F. M., Meijer, C. J., de Haan, L., van Beveren, N. J. M., for GROUPa; aGenetic Risk and Outcome of Psychosis investigators:, Kahn, R. S., de Haan, L., et al. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv133 · Cited by 39
Biofeedback to treat anxiety in young people at clinical high risk for developing psychosis
McAusland, L., & Addington, J. (2018) · Early Intervention in Psychiatry · doi:10.1111/eip.12368 · Cited by 37
Minichino, A., Davies, C., Karpenko, O., Christodoulou, G. N., Ramalho, R., Nandha, S., Damiani, S., Provenzani, U., Esposito, C. M., Mensi, M. M., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-02902-8 · Cited by 47
The Relationship of Developmental Changes in White Matter to the Onset of Psychosis
Karlsgodt, K. H., Jacobson, S. C., Seal, M. L., & Fusar‐Poli, P. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799316073 · Cited by 35
Clark, S. R., Schubert, K. O., & Baune, B. T. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1325-9 · Cited by 37
Trim the fat: the role of omega-3 fatty acids in psychopharmacology
Nasir, M., & Bloch, M. H. (2019) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125319869791 · Cited by 38
Clinical implications of oxidative stress in schizophrenia: Acute relapse and chronic stable phase
Chien, Y., Hwu, H., Hwang, T., Hsieh, M. H., Liu, C., Lin‐Shiau, S., & Liu, C.-M. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.109868 · Cited by 37
Akter, K. A., Gallo, D., Martin, S. A., Myronyuk, N., Roberts, R. T., Stercula, K., & Raffa, R. B. (2011) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2011.01265.x · Cited by 38
Venables, P. H., & Raine, A. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.11081173 · Cited by 38
Family Psychoeducation in Clinical High Risk and First-Episode Psychosis
McFarlane, W. R., Lynch, S. B., & Melton, R. P. (2012) · Adolescent Psychiatry · doi:10.2174/2210676611202020182 · Cited by 38
Smesny, S., Milleit, B., Schaefer, M. R., Hipler, U.-C., Milleit, C., Wiegand, C., Hesse, J., Klier, C. M., Holub, M., Holzer, I., et al. (2015) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2015.07.001 · Cited by 36
Self-citationEgerton, A., Fusar-Poli, P., & M. Stone, J. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799316244 · Cited by 36
Early Intervention in Schizophrenia: A Literature Review
Cheng, S. C., & Schepp, K. G. (2016) · Archives of Psychiatric Nursing · doi:10.1016/j.apnu.2016.02.009 · Cited by 36
Effects of Omega 3 Fatty Acids on Main Dimensions of Psychopathology
Bozzatello, P., Rosa, M. L. D., Rocca, P., & Bellino, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176042 · Cited by 35
Identification and characterization of new Δ-17 fatty acid desaturases
Xue, Z., He, H., Hollerbach, D. H., Macool, D. J., Yadav, N. S., Zhang, H., Szostek, B., & Zhu, Q. (2012) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-012-4068-2 · Cited by 37
Increases in seizure latencies induced by subcutaneous docosahexaenoic acid are lost at higher doses
Trépanier, M., Taha, A. Y., Mantha, R. L., Ciobanu, F. A., Zeng, Q. H., Tchkhartichvili, G. M., Domenichiello, A. F., Bazinet, R. P., & Burnham, W. M. (2012) · Epilepsy Research · doi:10.1016/j.eplepsyres.2011.12.001 · Cited by 35
Narendran, R., Frankle, W. G., Mason, N. S., Muldoon, M. F., & Moghaddam, B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046832 · Cited by 36
Su, K. (2015) · Biomedicine · doi:10.7603/s40681-015-0021-x · Cited by 38
Erythrocyte glutathione levels as long-term predictor of transition to psychosis
Lavoie, S., Berger, M., Schlögelhofer, M., Schäfer, M. R., Rice, S., Kim, S.-W., Hesse, J., McGorry, P. D., Smesny, S., & Amminger, G. P. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.30 · Cited by 35
Self-citationPawełczyk, T., Grancow-Grabka, M., Trafalska, E., Szemraj, J., & Pawełczyk, A. M. (2017) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2017.05.004 · Cited by 35
Lavoie, S., Jack, B. N., Griffiths, O., Ando, A., Amminger, G. P., Couroupis, A., Jago, A., Markulev, C., McGorry, P. D., Nelson, B., et al. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.11.005 · Cited by 35
Self-citationNeuroinflammation and oxidative stress in schizophrenia: are these opportunities for repurposing?
Ansari, Z., Pawar, S. R., & Seetharaman, R. (2021) · Postgraduate Medicine · doi:10.1080/00325481.2021.2006514 · Cited by 35
El‐Sisi, A. E., Sokar, S. S., El‐Sayad, M. E., Ramadan, E. S., & Osman, E. Y. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.05.024 · Cited by 35
Can neuroimaging be used to predict the onset of psychosis?
McGuire, P. K., Sato, J. R., Mechelli, A., Jackowski, A. P., Bressan, R. A., & Zugman, A. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00308-9 · Cited by 35
Polyunsaturated fatty acids in emerging psychosis: a safer alternative?
Schlögelhofer, M., Amminger, G. P., Schaefer, M. R., Fusar‐Poli, P., Smesny, S., McGorry, P. D., Berger, G. E., & Mossaheb, N. (2014) · Early Intervention in Psychiatry · doi:10.1111/eip.12151 · Cited by 34
Self-citationDrug repurposing and emerging adjunctive treatments for schizophrenia
Bumb, J. M., Enning, F., & Leweke, F. M. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1032248 · Cited by 33
Joa, I., Gisselgård, J., Brønnick, K., McGlashan, T. H., & Johannessen, J. O. (2015) · BMC Psychiatry · doi:10.1186/s12888-015-0470-5 · Cited by 35
Mossaheb, N., Schäfer, M. R., Schlögelhofer, M., Klier, C. M., Cotton, S., McGorry, P. D., & Amminger, G. P. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.05.027 · Cited by 34
Self-citationCurrent understandings about cognition and the neurobiological correlates in schizophrenia
Kar, S. K., & Jain, M. (2016) · Journal of Neurosciences in Rural Practice · doi:10.4103/0976-3147.176185 · Cited by 37
Schlosser, D. A., Miklowitz, D. J., O’Brien, M. P., Silva, S. D. D., Zinberg, J. L., & Cannon, T. D. (2011) · Early Intervention in Psychiatry · doi:10.1111/j.1751-7893.2011.00317.x · Cited by 33
Salokangas, R. K. R., Heinimaa, M., From, T., Löyttyniemi, E., Ilonen, T., Luutonen, S. H., Hietala, J. A., Svirskis, T., von Reventlow, H. G., Juckel, G., et al. (2013) · European Psychiatry · doi:10.1016/j.eurpsy.2013.10.003 · Cited by 33
Transcriptomic Analysis of the Effects of a Fish Oil Enriched Diet on Murine Brains
Hammamieh, R., Chakraborty, N., Gautam, A., Miller, S., Muhie, S. Y., Meyerhoff, J. L., & Jett, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090425 · Cited by 33
(N-3) Fatty Acids: Molecular Role and Clinical Uses in Psychiatric Disorders
Prior, P. L., & Galduróz, J. C. F. (2012) · Advances in Nutrition · doi:10.3945/an.111.001693 · Cited by 35
Hennig, T., Jaya, E. S., Koglin, U., & Lincoln, T. M. (2016) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-016-0904-8 · Cited by 33
Multidisciplinary Treatment for Individuals at Clinical High Risk of Developing Psychosis
Addington, J., Devoe, D. J. A., & Santesteban‐Echarri, O. (2019) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-019-0164-6 · Cited by 33
Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical Trial
Berger, M., Nelson, B., Markulev, C., Yuen, H. P., Schäfer, M. R., Mossaheb, N., Schlögelhofer, M., Smesny, S., Hickie, I. B., Berger, G. E., et al. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00393 · Cited by 35
Self-citationFarris, M. S., Devoe, D. J. A., & Addington, J. (2019) · Early Intervention in Psychiatry · doi:10.1111/eip.12864 · Cited by 37
Evaluation and Treatment of Children and Adolescents With Psychotic Symptoms
Algon, S., Yi, J. J., Calkins, M. E., Kohler, C. G., & Borgmann‐Winter, K. E. (2012) · Current Psychiatry Reports · doi:10.1007/s11920-012-0258-y · Cited by 32
Gohlke, J. M. (2012) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2012.00062 · Cited by 32
Kim, E. J., Lim, S. Y., Lee, H. J., Lee, J., Choi, S., Kim, S., Kim, J., Shin, I., Yoon, J., Yang, S. J., et al. (2017) · Nutrition Research · doi:10.1016/j.nutres.2017.07.001 · Cited by 33
The Adenosine Neuromodulation System in Schizophrenia
Rial, D., Lara, D. R., & Cunha, R. A. (2014) · International review of neurobiology · doi:10.1016/b978-0-12-801022-8.00016-7 · Cited by 35
Zhuo, C., Hou, W., Tian, H., Wang, L., & Li, R. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-01080-1 · Cited by 32
Effect of Vitamin D Supplementation on Outcomes in People With Early Psychosis
Gaughran, F., Stringer, D., Wojewodka, G., Landau, S., Smith, S. M., Gardner-Sood, P., Taylor, D. M., Jordan, H., Whiskey, E., Krivoy, A., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.40858 · Cited by 36
Hamazaki, K., Maekawa, M., Toyota, T., Iwayama, Y., Dean, B., Hamazaki, T., & Yoshikawa, T. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.01.014 · Cited by 35
Practitioner perceptions of attenuated psychosis syndrome
Jacobs, E., Kline, E. R., & Schiffman, J. E. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.06.022 · Cited by 31
Shrivastava, A., McGorry, P. D., Tsuang, M. T., Woods, S., Cornblatt, B. A., Corcoran, C. M., & Carpenter, W. T. (2011) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.75560 · Cited by 30
Self-citationMetabolic Syndrome and Cognitive Functions in Schizophrenia—Implementation of Dietary Intervention
Adamowicz, K., Mazur, A., Mak, M., Samochowiec, J., & Kucharska–Mazur, J. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00359 · Cited by 32
Mental Health in Childhood and Adolescence: The Role of Polyunsaturated Fatty Acids
Bozzatello, P., Blua, C., Rocca, P., & Bellino, S. (2021) · Biomedicines · doi:10.3390/biomedicines9080850 · Cited by 30
The Borders of Mental Disorder in Psychiatry and the DSM
Pierre, J. M. (2010) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000390756.37754.68 · Cited by 31
Wood, S. J., Cocchi, L., Proffitt, T., McConchie, M., Jackson, G. D., Takahashi, T., Pantelis, C., McGorry, P. D., & Berger, G. E. (2010) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2009.12.003 · Cited by 30
Self-citationCao, T., Li, N., & Cai, H. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.03.009 · Cited by 30
Should a risk syndrome for first episode psychosis be included in the DSM-5?
Nelson, B., & Yung, A. R. (2010) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32834190cd · Cited by 29
Lavoie, S., Schäfer, M. R., Whitford, T. J., Benninger, F., Feucht, M., Klier, C. M., Yuen, H. P., Pantelis, C., McGorry, P. D., & Amminger, G. P. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.03.033 · Cited by 29
Self-citationPrenatal choline and the development of schizophrenia.
Freedman, R., & Ross, R. G. (2015) · Europe PMC (PubMed Central) · doi:10.11919/j.issn.1002-0829.215006 · Cited by 29
Flynn, D., Smith, D., Quirke, L., Monks, S., & Kennedy, H. G. (2012) · BMC Psychiatry · doi:10.1186/1471-244x-12-100 · Cited by 29
Trebatická, J., Hradečná, Z., Böhmer, F., Vaváková, M., Waczulı́ková, I., Garaiová, I., Luha, J., Škodáček, I., Šuba, J., & Ďuračková, Z. (2017) · Child and Adolescent Psychiatry and Mental Health · doi:10.1186/s13034-017-0167-2 · Cited by 30
Pawełczyk, T., Grancow-Grabka, M., Trafalska, E., Szemraj, J., Żurner, N., & Pawełczyk, A. M. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.12.008 · Cited by 29
Katdare, A., Thakkar, S., Dhepale, S., Khunt, D., & Misra, M. (2019) · Nutrition · doi:10.1016/j.nut.2019.03.008 · Cited by 32
Pharmacotherapy in Children and Adolescents at Clinical-High Risk for Psychosis and Bipolar Disorder
Lambert, M., Niehaus, V., & Correll, C. U. (2016) · Pharmacopsychiatry · doi:10.1055/s-0042-116668 · Cited by 28
Models Predicting Psychosis in Patients With High Clinical Risk: A Systematic Review
Montemagni, C., Bellino, S., Bracale, N., Bozzatello, P., & Rocca, P. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00223 · Cited by 27
Deslauriers, J., Racine, W., Sarret, P., & Grignon, S. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.04.061 · Cited by 29
Fish consumption and resilience to depression in Japanese company workers: a cross-sectional study
Yoshikawa, E., Nishi, D., & Matsuoka, Y. (2015) · Lipids in Health and Disease · doi:10.1186/s12944-015-0048-8 · Cited by 27
Mongan, D., Healy, C., Jones, H. J., Zammit, S., Cannon, M. D., & Cotter, D. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01425-4 · Cited by 30
Frajerman, A., Scoriels, L., Kébir, O., & Chaumette, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136881 · Cited by 31
Tiffin, P. A., & Welsh, P. (2013) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12136 · Cited by 29
Quality Properties, Fatty Acids, and Biogenic Amines Profile of Fresh Tilapia Stored in Ice
Kulawik, P., Özoğul, F., & Glew, R. H. (2013) · Journal of Food Science · doi:10.1111/1750-3841.12149 · Cited by 27
Preventing breast cancer in women with schizophrenia
Seeman, M. V. (2010) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2010.01626.x · Cited by 27
Kim, S.-W., Schäfer, M., Klier, C., Berk, M., Rice, S., Allott, K., Bartholomeusz, C., Whittle, S., Pilioussis, E., Pantelis, C., et al. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.06.032 · Cited by 27
Self-citationEarly intervention in psychotic disorders: Challenges and relevance in the Indian context
Keshavan, M., Shrivastava, A., & Gangadhar, B. N. (2010) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.69228 · Cited by 27
Self‐awareness of functional impairment in individuals at clinical high‐risk for psychosis
Olvet, D. M., Carrión, R. E., Auther, A. M., & Cornblatt, B. A. (2013) · Early Intervention in Psychiatry · doi:10.1111/eip.12086 · Cited by 27
Zugno, A. I., Chipindo, H. L., Canever, L., Budni, J., de Castro, A. A., de Oliveira, M. B., Heylmann, A. S., Wessler, P. G., Silveira, F. D. R., Damázio, L. S., et al. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.11.025 · Cited by 26
Rutigliano, G., Manalo, M., & Fusar‐Poli, P. (2016) · Key issues in mental health (Online)/Key issues in mental health (Print) · doi:10.1159/000440914 · Cited by 26
Future perspectives on the treatment of cognitive deficits and negative symptoms in schizophrenia
GOFF, D. C. (2013) · World Psychiatry · doi:10.1002/wps.20026 · Cited by 25
Lachman, A. (2014) · Journal of Child and Adolescent Mental Health · doi:10.2989/17280583.2014.924416 · Cited by 26
Smesny, S., Milleit, B., Schaefer, M. R., Hesse, J., Schlögelhofer, M., Langbein, K., Hipler, U., Berger, M., Cotter, D., Sauer, H., et al. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.01.026 · Cited by 26
Self-citationLongitudinal Analyses of Blood Transcriptome During Conversion to Psychosis
Chaumette, B., Kébir, O., Pouch, J., Ducos, B., Selimi, F., ICAAR study group, Gaillard, R., & Krebs, M. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sby009 · Cited by 26
Mental health, physical health, and health-related behaviors of U.S. Army Special Forces
Cooper, A. D., Warner, S. G., Rivera, A. C., Rull, R. P., Adler, A. B., Faix, D. J., Neff, R., Deagle, E. A., Caserta, R. J., LeardMann, C. A., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0233560 · Cited by 30
Is Dopamine Neurotransmission Altered in Prodromal Schizophrenia? A Review of the Evidence
Bauer, M., Praschak-Rieder, N., Kasper, S. F., & Willeit, M. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799958611 · Cited by 24
Attenuated Psychosis Syndrome: Need for Debate on a New Disorder
Carpenter, W. T. (2014) · Psychopathology · doi:10.1159/000365221 · Cited by 24
Taylor, J. H., Bermúdez-Gómez, J., Zhou, M., Gómez, Ó., Ganz-Leary, C., Palacios, C., Huque, Z. M., Barzilay, R., Goldsmith, D. R., & Gur, R. E. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.12.019 · Cited by 27
Metadata
- Authors
- Amminger, G. P., Schäfer, M. R., Papageorgiou, K., Klier, C. M., Cotton, S. M., Harrigan, S. M., Mackinnon, A., McGorry, P. D., & Berger, G. E.
- Affiliations
- Medical University of Vienna (AT)
- The University of Melbourne (AU)
- Clienia AG (CH)
- ORCID
- Venue
- Archives of General Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 2010-02-01
- Volume
- 67
- Issue
- 2
- Pages
- 146
- ISSN
- 0003-990X (ISSN-L)
- OpenAlex
- W2130372506
- Cited by
- 896
- References
- 45
- Citations by year
- 2026: 13 · 2025: 20 · 2024: 29 · 2023: 22 · 2022: 20 · 2021: 51 · 2020: 42 · 2019: 59 · 2018: 33 · 2017: 52 · 2016: 69 · 2015: 82 · 2014: 95 · 2013: 85 · 2012: 98
- FWCI
- 92.57
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Archives of General Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Stanley Medical Research Institute (03T-315)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Keywords
- omega-3 polyunsaturated fatty acids, clinical high risk for psychosis, schizophrenia, adolescents and young adults, n-6/n-3 ratio, erythrocyte fatty acids, positive symptoms, negative symptoms, functional outcome, dietary supplementation, psychosis prevention, omega-3 deficiency
- MeSH terms
- Adolescent, Adult, Dose-Response Relationship, Drug, Double-Blind Method, Female, Health Status, Humans, Male, Patient Acceptance of Health Care, Psychotic Disorders, Risk Factors, Schizotypal Personality Disorder, Severity of Illness Index, Fatty Acids, Omega-3, Treatment Outcome, Diagnostic and Statistical Manual of Mental Disorders, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
